198 related articles for article (PubMed ID: 11695832)
21. Probing the ubiquinone reduction site of mitochondrial complex I using novel cationic inhibitors.
Miyoshi H; Inoue M; Okamoto S; Ohshima M; Sakamoto K; Iwamura H
J Biol Chem; 1997 Jun; 272(26):16176-83. PubMed ID: 9195916
[TBL] [Abstract][Full Text] [Related]
22. Essential structural factors of acetogenins, potent inhibitors of mitochondrial complex I.
Motoyama T; Yabunaka H; Miyoshi H
Bioorg Med Chem Lett; 2002 Aug; 12(16):2089-92. PubMed ID: 12127510
[TBL] [Abstract][Full Text] [Related]
23. Steady-state kinetics of the reduction of coenzyme Q analogs by complex I (NADH:ubiquinone oxidoreductase) in bovine heart mitochondria and submitochondrial particles.
Fato R; Estornell E; Di Bernardo S; Pallotti F; Parenti Castelli G; Lenaz G
Biochemistry; 1996 Feb; 35(8):2705-16. PubMed ID: 8611577
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase by oxacarbocyanine dyes. A structure-activity study.
Anderson WM; Wood JM; Anderson AC
Biochem Pharmacol; 1993 May; 45(10):2115-22. PubMed ID: 8512593
[TBL] [Abstract][Full Text] [Related]
25. The role of phospholipids in the reduction of ubiquinone analogues by the mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase complex.
Ragan CI
Biochem J; 1978 Jun; 172(3):539-47. PubMed ID: 210762
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the reaction of decoupling ubiquinone with bovine mitochondrial respiratory complex I.
Masuya T; Okuda K; Murai M; Miyoshi H
Biosci Biotechnol Biochem; 2016 Aug; 80(8):1464-9. PubMed ID: 27140857
[TBL] [Abstract][Full Text] [Related]
27. Essential structural features of acetogenins: role of hydroxy groups adjacent to the bis-THF rings.
Abe M; Kenmochi A; Ichimaru N; Hamada T; Nishioka T; Miyoshi H
Bioorg Med Chem Lett; 2004 Feb; 14(3):779-82. PubMed ID: 14741288
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic effect of thiacarbocyanine dyes on human colon carcinoma cells and inhibition of bovine heart mitochondrial NADH-ubiquinone reductase activity via a rotenone-type mechanism by two of the dyes.
Anderson WM; Delinck DL; Benninger L; Wood JM; Smiley ST; Chen LB
Biochem Pharmacol; 1993 Feb; 45(3):691-6. PubMed ID: 8442768
[TBL] [Abstract][Full Text] [Related]
29. Fungal quinone pigments as oxidizers and inhibitors of mitochondrial NADH:ubiquinone reductase.
Bironaité DA; Cénas NK; Anusevicius ZJ; Medentsev AG; Akimenko VK; Usanov SA
Arch Biochem Biophys; 1992 Sep; 297(2):253-7. PubMed ID: 1497345
[TBL] [Abstract][Full Text] [Related]
30. Natural substances (acetogenins) from the family Annonaceae are powerful inhibitors of mitochondrial NADH dehydrogenase (Complex I).
Degli Esposti M; Ghelli A; Ratta M; Cortes D; Estornell E
Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):161-7. PubMed ID: 8037664
[TBL] [Abstract][Full Text] [Related]
31. H+/2e- stoichiometry of the nadh:ubiquinone reductase reaction catalyzed by submitochondrial particles.
Galkin AS; Grivennikova VG; Vinogradov AD
Biochemistry (Mosc); 2001 Apr; 66(4):435-43. PubMed ID: 11403652
[TBL] [Abstract][Full Text] [Related]
32. Specificity of pyridinium inhibitors of the ubiquinone reduction sites in mitochondrial complex I.
Miyoshi H; Iwata J; Sakamoto K; Furukawa H; Takada M; Iwamura H; Watanabe T; Kodama Y
J Biol Chem; 1998 Jul; 273(28):17368-74. PubMed ID: 9651320
[TBL] [Abstract][Full Text] [Related]
33. Structural factors of rotenone required for inhibition of various NADH-ubiquinone oxidoreductases.
Ueno H; Miyoshi H; Inoue M; Niidome Y; Iwamura H
Biochim Biophys Acta; 1996 Sep; 1276(3):195-202. PubMed ID: 8856105
[TBL] [Abstract][Full Text] [Related]
34. Acridones and quinolones as inhibitors of ubiquinone functions in the mitochondrial respiratory chain.
Oettmeier W; Masson K; Soll M; Reil E
Biochem Soc Trans; 1994 Feb; 22(1):213-6. PubMed ID: 8206232
[No Abstract] [Full Text] [Related]
35. Direct interaction between mitochondrial succinate-ubiquinone and ubiquinol-cytochrome c oxidoreductases probed by sensitivity to quinone-related inhibitors.
Yamashita A; Miyoshi H; Hatano T; Iwamura H
J Biochem; 1996 Aug; 120(2):377-84. PubMed ID: 8889824
[TBL] [Abstract][Full Text] [Related]
36. Pro- and anti-oxidant activities of the mitochondrial respiratory chain: factors influencing NAD(P)H-induced lipid peroxidation.
Glinn MA; Lee CP; Ernster L
Biochim Biophys Acta; 1997 Jan; 1318(1-2):246-54. PubMed ID: 9030267
[TBL] [Abstract][Full Text] [Related]
37. On the mechanism of inhibition of NADH oxidase by ubiquinone-3.
Landi L; Pasquali P; Cabrini L; Sechi AM; Lenaz G
J Bioenerg Biomembr; 1984 Apr; 16(2):153-66. PubMed ID: 6536673
[TBL] [Abstract][Full Text] [Related]
38. Heterocyclic analogues of squamocin as inhibitors of mitochondrial complex I. On the role of the terminal lactone of annonaceous acetogenins.
Duval RA; Lewin G; Peris E; Chahboune N; Garofano A; Dröse S; Cortes D; Brandt U; Hocquemiller R
Biochemistry; 2006 Feb; 45(8):2721-8. PubMed ID: 16489765
[TBL] [Abstract][Full Text] [Related]
39. The NADH oxidation domain of complex I: do bacterial and mitochondrial enzymes catalyze ferricyanide reduction similarly?
Zickermann V; Kurki S; Kervinen M; Hassinen I; Finel M
Biochim Biophys Acta; 2000 Jul; 1459(1):61-8. PubMed ID: 10924899
[TBL] [Abstract][Full Text] [Related]
40. Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase.
Friedrich T; van Heek P; Leif H; Ohnishi T; Forche E; Kunze B; Jansen R; Trowitzsch-Kienast W; Höfle G; Reichenbach H
Eur J Biochem; 1994 Jan; 219(1-2):691-8. PubMed ID: 8307034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
